Your browser doesn't support javascript.
loading
Bone morphogenetic protein 7 promotes resistance to immunotherapy.
Cortez, Maria Angelica; Masrorpour, Fatemeh; Ivan, Cristina; Zhang, Jie; Younes, Ahmed I; Lu, Yue; Estecio, Marcos R; Barsoumian, Hampartsoum B; Menon, Hari; Caetano, Mauricio da Silva; Ramapriyan, Rishab; Schoenhals, Jonathan E; Wang, Xiaohong; Skoulidis, Ferdinandos; Wasley, Mark D; Calin, George; Hwu, Patrick; Welsh, James W.
Afiliação
  • Cortez MA; Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. MACortez@mdanderson.org.
  • Masrorpour F; Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Ivan C; Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Zhang J; Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Younes AI; Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Lu Y; Epigenetic and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Estecio MR; Epigenetic and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Barsoumian HB; Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Menon H; Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Caetano MDS; Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Ramapriyan R; Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Schoenhals JE; Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Wang X; Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Skoulidis F; Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Wasley MD; Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Calin G; Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Hwu P; Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Welsh JW; Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Nat Commun ; 11(1): 4840, 2020 09 24.
Article em En | MEDLINE | ID: mdl-32973129
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Resistencia a Medicamentos Antineoplásicos / Proteína Morfogenética Óssea 7 / Imunoterapia / Neoplasias Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Resistencia a Medicamentos Antineoplásicos / Proteína Morfogenética Óssea 7 / Imunoterapia / Neoplasias Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article